SCHEMBL6729370

SCHEMBL6729370

COCOc1c(C(C)(C)C)cc(C=[N+]([O-])CC2CCCCC2)cc1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5983928 0.77 ALDH1A1 (0.33)
SCHEMBL6727016 0.75
SCHEMBL6726973 0.74 BCHE (0.34)
SCHEMBL5984765 0.70
SCHEMBL27551737 0.69
SCHEMBL5984227 0.68 GABBR2 (0.34)
SCHEMBL5984261 0.67 ALDH1A1 (0.30)
SCHEMBL6731668 0.65 RXRA (0.32)
SCHEMBL6270579 0.64 ALDH1A1 (0.36)
SCHEMBL8807107 0.63 ALDH1A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6835754-B2 Administering alpha-(4-hydroxy-3,5-di-tert-butylphenyl)-N-tert-octylnitrone for example RENOVIS, INC. 2004-12-28 US disclosed
US-20040209958-A1 Use of aryl nitrone compounds in methods for treating neuropathic pain RENOVIS, INC. 2004-10-21 US disclosed
US-20020165274-A1 Use of aryl nitrone compounds in methods for treating neuropathic pain RENOVIS, INC. 2002-11-07 US disclosed